Thus, in this study, we established a novel liver-specific Kdm2a KO mouse model to evaluate whether deficiency of KDM2A in the liver leads to increased expression of NF-κB target genes and abnormal liver function, which are characteristic of metabolic disorders and diabetes. This evidence concerns the gene NFKB1 and metabolic disease.